首页|期刊导航|中国中药杂志|盘龙七片研究现状及前沿趋势可视化分析

盘龙七片研究现状及前沿趋势可视化分析OA

Visual analysis of research status and frontier trend of Panlongqi Tablets

中文摘要英文摘要

通过文献计量学与 CiteSpace 可视化软件,分析与挖掘中药复方盘龙七片的研究热点与方向,为相关研究提供方向.检索中国知网(CNKI)、万方(Wanfang)、维普(VIP)、中国生物医学文献服务系统(SinoMed)及 Web of Science 数据库,从建库至 2025 年 1 月 8 日有关盘龙七片的相关文献,使用 CiteSpace 6.3 R1 软件进行可视化分析.最终盘龙七片纳入 160 篇文献,以临床发文为主;有 9 篇指南推荐用药,有 6 项发明专利.存在多个发文团队与机构,发文量最多的为张德柱和林娜团队(各5 篇),陕西盘龙药业集团股份有限公司和中国中医科学院为主要发文机构,不同作者与机构之间合作较少.关键词分析方面,主要关键词有"对照研究""骨折""类风湿关节炎""骨关节炎""Meta 分析""网络药理学"等;共获得 19 个聚类,汇集成4 个聚类主题词:临床研究、药理实验、化学成分、安全用药.当前热点主要集中在骨关节炎、骨折等骨伤科疾病的临床疗效评价和药理作用研究、有效成分含量测定与用药安全性等.未来研究可结合多学科技术和人工智能,充分挖掘以盘龙七片为代表的"七药"的临床作用特点和优势,拓展适应证,完备更明确的安全界定.

Through bibliometrics and CiteSpace visualization software,this study explored the hot spots and directions of research on the Chinese medicine compound Panlongqi Tablets,providing directions for related research.The databases of CNKI,Wanfang,VIP,SinoMed,and Web of Science were searched.CiteSpace 6.3 R1 software was used for visual analysis of the relevant literature on Panlongqi Tablets from the establishment of these databases to January 8,2025.Finally,160 pieces of literature on Panlongqi Tablets were included,mainly clinical papers.Panlongqi Tablets were recommended by nine guidelines and had six invention patents.There are multiple publishing teams and institutions,with the team of ZHANG De-zhu and LIN Na having the largest number of publications(five papers each).Shaanxi Panlong Pharmaceutical Group Limited by Share LTD.and China Academy of Chinese Medical Sciences are the main publishing institutions,and there is less cooperation between different authors and institutions.In terms of keyword analysis,the main keywords are"controlled study""fracture""rheumatoid arthritis""osteoarthritis""Meta-analysis""network pharmacology",and so on.A total of 19 clusters were obtained,which were grouped into four cluster themes:clinical research,pharmacological experiments,chemical components,and safe drug use.The current focus is mainly on the evaluation of clinical efficacy and pharmacological effects of osteoarthritis,fracture,and other orthopedic diseases,the determination of effective components of Panlongqi Tablets,and drug safety.Future research can combine multidisciplinary technology and artificial intelligence to fully explore the clinical characteristics and advantages of the"Qi yao"represented by Panlongqi Tablets,expand the indications,and complete a clearer definition of safety.

王佳琳;李晓萱;严倩倩;赵清玉;许丽婷;王丽丽;韩腾飞;刘春芳;林娜

承德医学院 中药研究所,河北 承德 067000||中国中医科学院 中药研究所,北京 100700中国中医科学院 中药研究所,北京 100700中国中医科学院 中药研究所,北京 100700中国中医科学院 中药研究所,北京 100700中国中医科学院 中药研究所,北京 100700中国中医科学院 中药研究所,北京 100700陕西盘龙药业集团股份有限公司,陕西 西安 710025中国中医科学院 中药研究所,北京 100700承德医学院 中药研究所,河北 承德 067000||中国中医科学院 中药研究所,北京 100700

盘龙七片七药CiteSpace文献计量学可视化发展预测

Panlongqi TabletsQi yaoCiteSpacebibliometricsvisualizationdevelopment forecast

《中国中药杂志》 2026 (17)

4817-4826,10

中国中医科学院中药研究所技术服务项目(H2024003)国家"重大新药创制"科技重大专项(2019ZX09731002)

10.19540/j.cnki.cjcmm.20250320.401

评论